Bohnen Shane 4

What Happened

• Shane Bohnen, SVP and General Counsel of Bio‑Techne (TECH), had 2,259 restricted stock units vest on April 3, 2026 (reported Apr 7, 2026). Of those shares, 740 were withheld to cover tax withholding at $53.13 per share (total value $39,316). The filing shows the vesting/conversion (transaction code M) and the tax withholding (transaction code F).

Key Details

• Transaction dates: vesting/conversion and withholding occurred 2026-04-03; Form 4 filed 2026-04-07 (timely).
• Prices and values: withheld 740 shares at $53.13 = $39,316. The RSUs converted/vested at $0 on the form (typical reporting for RSU vesting/conversion); the economic value is implied by the market price used for withholding.
• Net new shares received: 2,259 vested − 740 withheld = 1,519 shares retained by Bohnen.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Relevant footnote: F5 indicates "2,259 restricted stock units vest on 4/3/2026." Transaction codes: M = exercise/conversion of derivative (here, RSU vesting/conversion); F = payment of exercise price or tax liability (withholding).
• No indication of a 10b5‑1 plan, gift, or open‑market sale in this filing.

Context

• This was a routine vesting of RSUs with shares withheld to satisfy tax obligations (a common cashless withholding). That withholding is not an open‑market sale signaling a deliberate sell decision; it’s to cover taxes. The filing appears timely under Form 4 rules.